Antiviral Agents: Discovery to Resistance.
Identifieur interne : 000987 ( 2020/Analysis ); précédent : 000986; suivant : 000988Antiviral Agents: Discovery to Resistance.
Auteurs : Catherine S. Adamson [Royaume-Uni]Source :
- Viruses [ 1999-4915 ] ; 2020.
Descripteurs français
- KwdFr :
- MESH :
- pharmacologie : Antiviraux.
- traitement médicamenteux : Maladies virales.
- usage thérapeutique : Antiviraux.
- virologie : Maladies virales.
- Animaux, Humains, Résistance virale aux médicaments.
English descriptors
- KwdEn :
- MESH :
- chemical , pharmacology : Antiviral Agents.
- chemical , therapeutic use : Antiviral Agents.
- drug therapy : Virus Diseases.
- virology : Virus Diseases.
- Animals, Drug Resistance, Viral, Humans.
Abstract
In the midst of the SARS-CoV-2/Covid-19 outbreak the need for research into, and development of, antiviral agents is brought into sharp focus worldwide for scientists, governments and the public alike [...].
DOI: 10.3390/v12040406
PubMed: 32272550
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000255
- to stream PubMed, to step Curation: 000255
- to stream PubMed, to step Checkpoint: 000781
- to stream Ncbi, to step Merge: 003854
- to stream Ncbi, to step Curation: 003854
- to stream Ncbi, to step Checkpoint: 003854
- to stream Main, to step Merge: 000987
- to stream Main, to step Curation: 000987
- to stream Main, to step Exploration: 000987
- to stream 2020, to step Extraction: 000987
Links to Exploration step
pubmed:32272550Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Antiviral Agents: Discovery to Resistance.</title><author><name sortKey="Adamson, Catherine S" sort="Adamson, Catherine S" uniqKey="Adamson C" first="Catherine S" last="Adamson">Catherine S. Adamson</name><affiliation wicri:level="1"><nlm:affiliation>School of Biology, Biomedical Sciences Research Complex, University of St Andrews, St Andrews KY16 9ST, Scotland, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>School of Biology, Biomedical Sciences Research Complex, University of St Andrews, St Andrews KY16 9ST, Scotland</wicri:regionArea><wicri:noRegion>Scotland</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32272550</idno><idno type="pmid">32272550</idno><idno type="doi">10.3390/v12040406</idno><idno type="wicri:Area/PubMed/Corpus">000255</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000255</idno><idno type="wicri:Area/PubMed/Curation">000255</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000255</idno><idno type="wicri:Area/PubMed/Checkpoint">000781</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000781</idno><idno type="wicri:Area/Ncbi/Merge">003854</idno><idno type="wicri:Area/Ncbi/Curation">003854</idno><idno type="wicri:Area/Ncbi/Checkpoint">003854</idno><idno type="wicri:Area/Main/Merge">000987</idno><idno type="wicri:Area/Main/Curation">000987</idno><idno type="wicri:Area/Main/Exploration">000987</idno><idno type="wicri:Area/2020/Extraction">000987</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Antiviral Agents: Discovery to Resistance.</title><author><name sortKey="Adamson, Catherine S" sort="Adamson, Catherine S" uniqKey="Adamson C" first="Catherine S" last="Adamson">Catherine S. Adamson</name><affiliation wicri:level="1"><nlm:affiliation>School of Biology, Biomedical Sciences Research Complex, University of St Andrews, St Andrews KY16 9ST, Scotland, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>School of Biology, Biomedical Sciences Research Complex, University of St Andrews, St Andrews KY16 9ST, Scotland</wicri:regionArea><wicri:noRegion>Scotland</wicri:noRegion></affiliation></author></analytic><series><title level="j">Viruses</title><idno type="eISSN">1999-4915</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Antiviral Agents (pharmacology)</term><term>Antiviral Agents (therapeutic use)</term><term>Drug Resistance, Viral</term><term>Humans</term><term>Virus Diseases (drug therapy)</term><term>Virus Diseases (virology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Antiviraux (pharmacologie)</term><term>Antiviraux (usage thérapeutique)</term><term>Humains</term><term>Maladies virales (traitement médicamenteux)</term><term>Maladies virales (virologie)</term><term>Résistance virale aux médicaments</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiviral Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Virus Diseases</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Antiviraux</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Maladies virales</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Maladies virales</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Virus Diseases</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Drug Resistance, Viral</term><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Humains</term><term>Résistance virale aux médicaments</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In the midst of the SARS-CoV-2/Covid-19 outbreak the need for research into, and development of, antiviral agents is brought into sharp focus worldwide for scientists, governments and the public alike [...].</div></front></TEI><affiliations><list><country><li>Royaume-Uni</li></country></list><tree><country name="Royaume-Uni"><noRegion><name sortKey="Adamson, Catherine S" sort="Adamson, Catherine S" uniqKey="Adamson C" first="Catherine S" last="Adamson">Catherine S. Adamson</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000987 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd -nk 000987 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= 2020
|étape= Analysis
|type= RBID
|clé= pubmed:32272550
|texte= Antiviral Agents: Discovery to Resistance.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/RBID.i -Sk "pubmed:32272550" \
| HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |